arginyl-glycyl-aspartyl-serine has been researched along with Cancer of Prostate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brite, KH; Chatterjee, S; Matsumura, A | 1 |
1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Cancer of Prostate
Article | Year |
---|---|
Induction of apoptosis of integrin-expressing human prostate cancer cells by cyclic Arg-Gly-Asp peptides.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrins; Male; Oligopeptides; Peptides, Cyclic; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Vitronectin; Tumor Cells, Cultured | 2001 |